Gene · 27074
Papers3,205
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,205
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the immune microenvironment for ovarian cancer therapy. | Front Immunol | 2023 | 38164130 | PubTator, text mining | PubMed |
| Potential impact of cuproptosis-related genes on tumor immunity in esophageal carcinoma. | Aging (Albany NY) | 2023 | 38159255 | PubTator, text mining | PubMed |
| Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy. | Front Immunol | 2023 | 38155965 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal POSTN+ cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer. | Clin Transl Med | 2023 | 38115703 | PubTator, text mining | PubMed |
| Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance. | Sci Rep | 2023 | 38110534 | PubTator, text mining | PubMed |
| A distinct human cell type expressing MHCII and RORγt with dual characteristics of dendritic cells and type 3 innate lymphoid cells. | Proc Natl Acad Sci U S A | 2023 | 38109523 | PubTator, text mining | PubMed |
| Editorial: Understanding the immuno-oncological mechanism of cancer using systems immunology approaches. | Front Immunol | 2023 | 38106425 | PubTator, text mining | PubMed |
| Harnessing immunotherapy for brain metastases: insights into tumor-brain microenvironment interactions and emerging treatment modalities. | J Hematol Oncol | 2023 | 38104104 | PubTator, text mining | PubMed |
| Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma. | Elife | 2023 | 38099574 | PubTator, text mining | PubMed |
| Methylsulfonylmethane ameliorates metabolic-associated fatty liver disease by restoring autophagy flux via AMPK/mTOR/ULK1 signaling pathway. | Front Pharmacol | 2023 | 38099147 | PubTator, text mining | PubMed |
| Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma. | Cancer Cell Int | 2023 | 38093298 | PubTator, text mining | PubMed |
| Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases. | eGastroenterology | 2023 | 38074919 | PubTator, text mining | PubMed |
| Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy. | ACS Appl Bio Mater | 2023 | 38063308 | PubTator, text mining | PubMed |
| Identification of interferon-stimulated genes with modulated expression during hepatitis E virus infection in pig liver tissues and human HepaRG cells. | Front Immunol | 2023 | 38058490 | PubTator, text mining | PubMed |
| Ambient atmospheric PM worsens mouse lung injury induced by influenza A virus through lysosomal dysfunction. | Respir Res | 2023 | 38057804 | PubTator, text mining | PubMed |
| Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations. | Nat Commun | 2023 | 38042900 | PubTator, text mining | PubMed |
| Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma. | J Immunother Cancer | 2023 | 38040418 | PubTator, text mining | PubMed |
| Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis. | J Clin Invest | 2023 | 38038136 | PubTator, text mining | PubMed |
| Dynamic regulatory elements in single-cell multimodal data implicate key immune cell states enriched for autoimmune disease heritability. | Nat Genet | 2023 | 38036783 | PubTator, text mining | PubMed |
| Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment. | Nat Commun | 2023 | 38036590 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27074/papers?page=17